Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Journal Club
  • Published:

Breakthrough in the prevention of mother-to-child hepatitis B transmission?

Manuscript Citation: Pan, et al. “Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.” N Engl J Med 2016; 374:2324-2334.

Journal of Perinatology volume 37, pages 333–334 (2017)Cite this article

Subjects

Treatment

In hepatitis B e antigen (HBeAg)-positive mothers with hepatitis B virus (HBV) DNA >200 000 IU ml−1, does tenofovir (TDF) prophylaxis administered from 30 to 32 weeks of gestation until 4 weeks postpartum compared with routine care without viral prophylaxis decrease mother-to-child transmission and birth defects?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS . A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34 (6): 1329–1339.

    Article  Google Scholar 

  2. Society for Maternal-Fetal M Society for Maternal-Fetal M, Dionne-Odom J, Society for Maternal-Fetal M, Tita AT, Society for Maternal-Fetal M, Silverman NS . #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstetr Gynecol 2016; 214 (1): 6–14.

    Article  Google Scholar 

  3. Zou H, Chen Y, Duan Z, Zhang H, Pan C . Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012; 19 (2): e18–e25.

    Article  CAS  Google Scholar 

  4. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016; 374 (24): 2324–2334.

    Article  CAS  Google Scholar 

  5. Nayeri UA, Werner EF, Han CS, Pettker CM, Funai EF, Thung SF . Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis. Am J Obstetr Gynecol 2012; 207 (3): 231 e231–231 e237.

    Article  Google Scholar 

  6. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16 (2): 94–103.

    Article  Google Scholar 

  7. Brown RS Jr, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli MA et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology 2016; 63 (1): 319–333.

    Article  CAS  Google Scholar 

  8. Benaboud S, Pruvost A, Coffie PA, Ekouévi DK, Urien S, Arrivé E et al. Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2. Antimicrob Agents Chemother 2011; 55 (3): 1315–1317.

    Article  CAS  Google Scholar 

  9. World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. WHO: Geneva, 2015.

  10. Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S . Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis 2015; 15 (8): 981–985.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neonatology Fellow PGY-5, Children’s Hospital of Georgia, Augusta University, Augusta, GA, USA

    E P Masoumy

  2. Neonatology-Pediatrics, Children’s Hospital of Georgia, Augusta University, Augusta, GA, USA

    B K Stansfield

Authors
  1. E P Masoumy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B K Stansfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E P Masoumy.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masoumy, E., Stansfield, B. Breakthrough in the prevention of mother-to-child hepatitis B transmission?. J Perinatol 37, 333–334 (2017). https://doi.org/10.1038/jp.2016.269

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2016.269

Search

Advanced search

Quick links